Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?

Published:2020-03-12 Issue: Volume:11 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

van Westrhenen Roos,Aitchison Katherine J.,Ingelman-Sundberg Magnus,Jukić Marin M.

Funder

Vetenskapsrådet

Horizon 2020 Framework Programme

Hjärnfonden

Philip Morris International

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference78 articles.

1. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis;Cipriani;Lancet,2018

2. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: amultiple-treatments meta-analysis;Leucht;Lancet,2013

3. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration;Kirsch;PloS Med,2008

4. Prediction of drug response and adverse drug reactions: from twin studies to nextgeneration sequencing;Lauschke;Eur J Pharm Sci,2019

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MALDI-TOF MS-based SNP assay used to determine the appropriate antidepression for Chinese patients;Journal of Pharmaceutical and Biomedical Analysis;2025-01

2. Mood disorders and suicide: pilot study on postmortem toxicologic evidence and adherence to psychiatric therapy by determining blood levels of medications;International Journal of Legal Medicine;2024-09-14

3. Effect of pharmacogenomic testing on the clinical treatment of patients with depressive disorder: A randomized clinical trial;Journal of Affective Disorders;2024-08

4. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants;European Journal of Human Genetics;2024-07-02

5. The present and the future of pharmacogenetic testing with focus on the pharmacotherapy of depression;Psychiatrie pro praxi;2024-06-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3